Sleep Number (SNBR) has capped FY 2025 with fourth quarter revenue of US$347.4 million and a basic EPS loss of US$2.55, as net income excluding extra items came in at a loss of US$58.5 million. The company has seen quarterly revenue move from US$393.3 million in Q1 2025 to US$327.9 million in Q2, US$342.9 million in Q3 and US$347.4 million in Q4, alongside a widening basic EPS loss over the same stretch. For investors, that mix of steady sales levels and deeper losses keeps the focus firmly on margins and how quickly profitability can be repaired.

See our full analysis for Sleep Number.

With the headline numbers on the table, the next step is to see how this trajectory lines up with the widely followed narratives around Sleep Number's risks, potential rewards and the timing of any earnings recovery.

Losses Widen Even As Sales Hold Around US$340 Million

• Over the last three quarters of FY 2025, revenue has hovered between US$327.9 million and US$347.4 million, while quarterly net losses excluding extra items widened from US$25.0 million in Q2 to US$58.5 million in Q4.
• Bulls point to planned 2026 changes as a way to make that revenue base work harder, but the current earnings profile is a clear hurdle:
  • Bullish narratives highlight a 2026 product reset, broader distribution and cost cuts that are intended to lift margins off a trailing 12 month loss of US$132.0 million.
  • At the same time, those bullish views assume margins can move from roughly negative mid single digits today toward breakeven over the next few years. This would require a sharp shift from four straight quarters of losses ranging from US$8.6 million to US$58.5 million.

Bulls argue these results are the painful part of a turnaround that could set up a margin story if the 2026 reset lands as planned. 🐂 Sleep Number Bull Case

Same Store Sales Slides Of 15% To 19% Test Bear Concerns

• Same store sales fell 15% in Q1 2025 and 19% in both Q2 and Q3, alongside quarterly revenue moving from US$393.3 million in Q1 to US$327.9 million in Q2 before edging back to US$347.4 million in Q4.
• Bears argue that intense competition and reliance on premium pricing could keep that pressure on, and the recent data does not yet contradict them:
  • The bearish narrative flags a crowded mattress market and aggressive promotions, which lines up with negative same store sales across all reported quarters from Q3 2024 through Q3 2025.
  • Even though management is planning more accessible price points and higher marketing spend, the trailing 12 month revenue of about US$1.4b still sits alongside ongoing losses, which keeps the cautious case very much alive for now.

Cautious investors suggest these sales trends need to stabilize before they put much weight on any longer term recovery story. 🐻 Sleep Number Bear Case

Deep Losses Versus Low P/S Valuation

• On a trailing 12 month basis, Sleep Number reported about US$1.4b of revenue and a net loss of US$132.0 million, while the shares trade on a P/S of 0.1x compared with 0.4x for the US Specialty Retail industry.
• What stands out is the gap between this loss profile and the upside implied by models and forecasts:
  • Current models point to DCF fair value of roughly US$16.10 per share versus a share price of US$3.67 and an allowed analyst price target of US$11.00. This is occurring even though the company is still unprofitable and carries negative shareholders’ equity.
  • Forecasts calling for very rapid earnings growth and a return to profit within three years sit alongside weak interest coverage and historically widening losses, so the low P/S multiple is being weighed against clear balance sheet and earnings risks.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Sleep Number on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If the mixed signals here leave you unsure, now is a good time to review the key data yourself and consider both perspectives, starting with 3 key rewards and 3 important warning signs.

Explore Alternatives

Sleep Number is working through deep losses, negative same store sales and balance sheet pressure, which may not appeal if you are focused on resilience.

If you want ideas with fewer financial red flags and a steadier profile, check out our 68 resilient stocks with low risk scores and see which companies better fit that brief.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.